arrow
E

Elizabeth Appleton

The Institute of Cancer Research
H指数:7
被引数:636

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes anti-tumour immunity in combination with radiotherapy

系统给药的第二代STING激动剂与放疗联合促进抗肿瘤免疫的预临床疗效

2026-10-150
OAAI
Xevinapant plus Chemoradiotherapy Negatively Sculpts the Tumor-Immune Microenvironment in Head and Neck Cancer

Xevinapant联合放化疗对头颈癌肿瘤免疫微环境的负面影响

2025-11-010
OA
Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion

作者更正: Palbociclib和dsRNA传感器合作通过ER应激和调节免疫逃避来增强抗癌作用

2025-07-150
OAAI
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models

PARP抑制剂talazoparib与呼肠孤病毒协同作用,在小鼠模型中体内诱导癌症杀伤和肿瘤控制

2025-07-080
OAAI
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion
2025-05-250
OAAI
Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade
2018-01-03302
OAAI